Search CROs

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services

ICON is a CRO with 8,000 biotech-dedicated professionals offering end-to-end clinical development, consulting, and therapeutic expertise across all development phases.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Integrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.

• Bioanalysis
• Clinical Operations
• Phase I Clinical Trials

Full-service CRO founded in 1999 providing therapeutic expertise across clinical trial and consulting services to pharmaceutical and biotechnology companies.

• Analytical Method Development & Validation
• Biostatistics & Statistical Programming
• Central Laboratory Services

Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. With over 30 years of background in regulatory trends, therapeutic experience, and operational expertise, the company partners with biopharma to advance…

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Operations

Caidya is a global, full-service CRO delivering personalized clinical development solutions across all phases of clinical research. The company specializes in early-phase development, Phase II/III studies, and clinical operations with deep expertise in oncology & hematology,…

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Clinical development CRO combining scientific, medical, and operational expertise with flexible structure to deliver high-quality data for complex clinical trials and cross-border studies.

• Analytical Method Development & Validation
• Biostatistics & Statistical Programming
• Clinical Operations

Global full-service CRO partnering with small and mid-size biopharma across all phases of drug development, with deep expertise in oncology, neuroscience, and infectious diseases.

• Bioanalysis
• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services

Full-service global CRO with 30+ years of therapeutic expertise, delivering personalized clinical trial support across rare disease, cardiovascular, cell & gene therapy, oncology, and neuroscience.

• Biostatistics & Statistical Programming
• Central Laboratory Services
• Clinical Operations

Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.

• Analytical Method Development & Validation
• Bioanalysis
• Biostatistics & Statistical Programming

Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.

• Bioinformatics & Data Science
• Biomarker Assays
• Central Laboratory Services

Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.